Prevalence and Characteristics of the Metabolic Syndrome in Primary Aldosteronism
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
CONTEXT: Patients with hypertension have a high prevalence of concurrent metabolic abnormalities, including obesity, dyslipidemia, and hyperglycemia. Clustering of these cardiovascular risk factors, defined as metabolic syndrome, causes a more pronounced target organ damage. Aldosterone excess has been found to be associated with glucose disorders and may contribute to cardiovascular damage. OBJECTIVE: The aim of our study was to assess the prevalence and the characteristics of the metabolic syndrome in a group of patients with hypertension due to primary aldosteronism compared with patients with essential hypertension. METHODS: The National Cholesterol Education Program Adult Treatment Panel III definition of the metabolic syndrome was used. Eighty-five patients with primary aldosteronism and 381 patients with essential hypertension were studied. Most patients were not receiving antihypertensive therapy during the investigation. RESULTS: Blood glucose and systolic blood pressure were higher (P < 0.05 and P < 0.01, respectively) and duration of hypertension was longer (P < 0.05) in primary aldosteronism than in essential hypertension. The prevalence of metabolic syndrome was higher in primary aldosteronism than in essential hypertension (41.1% vs. 29.6%; P < 0.05). Distribution of single components of the metabolic syndrome other than hypertension showed a higher prevalence of hyperglycemia in primary aldosteronism than in essential hypertension (27.0% vs. 15.2%; P < 0.05). CONCLUSIONS: Our findings confirm a negative effect of aldosterone excess on glucose metabolism and suggest that the recently reported higher rates of cardiovascular events in primary aldosteronism than in essential hypertension might be due to increased prevalence of the metabolic syndrome in the former condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Primary aldosteronism (PA) is associated with increased risk for dysglycemia.”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [6]
In the citing paper
“Higher plasma mineralocorticoid levels may be associated with IR (, ).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [166]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X., Plouin, P.-F., Blacher, J., Safar, M. E., & Mourad, J.-J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,547
The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension
Kaplan, N. M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.7.1514 · Cited by 1,516
Cited by
Items 301–376 of 376
Hyperaldostéronisme primaire chez l’enfant, à propos d’un cas
Dewez, J.-E., & Bachy, A. (2008) · Archives de Pédiatrie · doi:10.1016/j.arcped.2008.10.004 · Cited by 3
Comparison of Target Organ Damages between Primary Aldosteronism and Essential Hypertension
Park, J., Kim, D. J., Yang, S. J., Kim, S. H., Park, S. Y., Yoo, H. J., Lee, Y. J., Kim, H. Y., Ryu, O. H., Lee, K. W., et al. (2007) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2007.22.1.11 · Cited by 3
“원발성 알도스테론증 환자에서 심혈관 질환의 빈도가 높은 이유는 본태성 고혈압 환자에 비해 대사증후군의 유병률이 높기 때 문이고, 대사증후군에는 내당능 장애가 크게 기여하는 것으 로 보고한 최근 연구도 있었다[20].”
Kim, S. W. (2012) · Korean Journal of Medicine · doi:10.3904/kjm.2012.82.4.396 · Cited by 3
Chan, C., Lai, T., & Wu, V. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001549 · Cited by 3
Chan, C., Yang, W., Lin, Y., Wu, V., & Chueh, S. (2025) · Diabetes · doi:10.2337/db23-0273 · Cited by 2
Association between serum uric acid levels and primary aldosteronism
Zhao, X., Jiao, H., Zhang, R., Zhao, H., Ma, L., Jia, Z., Tang, Z., & Gu, Y. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04504-6 · Cited by 2
“Metabolic syndrome is a concern for endocrinolo-gists, and several clinical studies have found that metabolic abnormalities such as hyperglycemia, dyslipidemia, nonalcoholic fatty liver disease (NAFLD), and abdominal obesity are more frequent in patients with PA than in those with EH [13–15].”
Jochmanová, I., Habalová, V., Wagnerová, H., Galovičová, A., & Lazúrová, I. (2013) · Physiological Research · doi:10.33549/physiolres.932452 · Cited by 2
Metabolic syndrome and primary aldosteronism: time for reappraisal?
Fallo, F., & Sonino, N. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.76 · Cited by 2
Self-citationDrug-Induced Hyperglycemia and Diabetes Mellitus
McCullen, M. K., & Ahmed, I. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-35 · Cited by 2
Primary Aldosteronism: A Field on the Move
Doumas, M. N., & Δούμα, Σ. (2016) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-34141-5_2 · Cited by 3
Primary aldosteronism (Conn's syndrome)
Ceccato, F., Tizianel, I., Voltan, G., & Mantero, F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96120-2.00014-5 · Cited by 2
Autosomal dominant polycystic kidney disease and hypertension masquerading primary aldosteronism
Mital, P., Abhijit, K., & Shishir, G. (2017) · Indian Journal of Nephrology · doi:10.4103/ijn.ijn_330_16 · Cited by 1
Steroids and cardiovascular and metabolic disorders
Kumar, R., & McEwan, I. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91141-2.00003-9 · Cited by 2
Metabolic effects of aldosterone
Валерьевна, И. К., Mazurina, N. V., Platonova, N. M., & Troshina, E. A. (2024) · Obesity and metabolism · doi:10.14341/omet13040 · Cited by 1
Grasselli, C., Baldini, M., Salvi, L., Vestita, G., Zizzo, M., Felaco, D., Balli, M. C., Besutti, G., Negro, A., & Ghirarduzzi, A. (2025) · Diseases · doi:10.3390/diseases13020052 · Cited by 1
Zhao, C., Chen, F., Peng, L., Li, Q., Pang, Y., & Yue, C. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70532 · Cited by 1
“…but also increases the risk of insulin resistance, type 2 diabetes, osteoporosis, cardiovascular, and cerebrovascular complications in patients with primary aldo-steronism, compared to the general population and individuals with essential hypertension (Fallo et al. 2006, 2012; Hanslik et al. 2015).”
Benameur, S., Bertolino, J., Bonnaud, L., Nguyen, N. A. T., Leclercq, B., Silhol, F., Castinetti, F., Sebag, F., Vaisse, B., & Sarlon-Bartoli, G. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70128 · Cited by 1
“This may be associated with a higherprevalenceofhyperglycemiainPApatientscomparedwith patients with essential hypertension [11].”
Zhang, Z., Chen, C., Zhang, M., Zhu, J., Xu, X., Wang, Z., Zhou, L., Wu, C., Zong, M., Yin, T., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2657047 · Cited by 1
“48,49 Given that metabolic abnormalities often cluster in hypertensive individuals and contribute to cardiovascular risk, 50,51 the gut microbiota may serve as a potential contributing factor to the elevated cardiovascular risk in PA by modulating host metabolism.”
Link of Obesity With Primary Aldosteronism: Causal or Not?
Flack, J. M., Buhnerkempe, M., Lopez, A., & Byrd, J. B. (2026) · Hypertension · doi:10.1161/hypertensionaha.126.26227 · Cited by 1
Primary Aldosteronism: Progress in Diagnosis, Therapy, and Genetics
Mulatero, P., Williams, T. A., Monticone, S., Viola, A., Tizzani, D., Crudo, V. L., Burrello, J., & Veglio, F. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-548-4_1 · Cited by 1
Self-citationThe Relationship between Obesity, Insulin Resistance and Aldosterone Levels
Mazzuco, T. L. (2018) · Current Research in Diabetes & Obesity Journal · doi:10.19080/crdoj.2018.06.555680 · Cited by 1
“Both hyperglycemia and diabetes are more prevalent in hypertensive patients with PA than in those with essential hypertension [20,21].”
BackgroundPrimary Mineralocorticoid Excess Syndromes and Hypertension
Carey, R. M., & Padia, S. H. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00107-6 · Cited by 1
Hindle, E., Calzada-Nocaudie, M., Keller, I., & Askienazy, S. (2008) · Springer eBooks · doi:10.1007/978-3-540-28026-2_14 · Cited by 1
Regulation of Aldosterone Production
Monticone, S., Rainey, W. E., Bollag, W. B., & Isales, C. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-803247-3.00025-8 · Cited by 2
Thomas, T. S., Walpert, A. R., Shen, G., Dunderdale, C. N., & Srinivasa, S. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad015 · Cited by 1
“In addition to hypertension, individuals with PA are known to have cardiometabolic sequalae [8, 17], including CVD, arterial inflammation, stroke, and diabetes, which are all commonly themed as inflammatory-mediated processes.”
BackgroundClassic endocrine disorders: implications for cardiovascular disease
Krentz, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99991-5.00014-0 · Cited by 3
DAS METABOLISCHE SYNDROM DES MANNES - ENDOKRINOLOGISCHE BETRACHTUNG
Jockenhövel, F., & Moore, C. (2006) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1
Chun, T.-Y., & Pratt, J. H. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32814db86a · Cited by 1
Polycystic Ovary Syndrome and the Metabolic Syndrome
Janssen, O. E., Tan, S., Dietz, T., & Hahn, S. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-37 · Cited by 1
The regulation of preadipocyte differentiation by glucocorticoids
Tomlinson, J. J. (2007) · uO Research (University of Ottawa) · doi:10.20381/ruor-13103
Aldosterone and Cardiovascular Diseases
Tomaschitz, A., & Pilz, S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0509-6_12
Huang, C., Wang, W., Chien, H.-Y., Hsu, Y.-H., & Hsia, C. (2012) · 內科學誌 · doi:10.6314/jimt.2012.23(4).08
Nebennieren und Diabetes mellitus
Weismann, D., & Allolio, B. (2009) · Der Diabetologe · doi:10.1007/s11428-009-0436-7
Diabetes in Hyperaldosteronism
Crudo, V. L., Mulatero, P., Monticone, S., & Veglio, F. (2014) · Frontiers in diabetes · doi:10.1159/000357246
Self-citationComplicanze cardiometaboliche e renali nell’iperaldosteronismo primario
Giacchetti, G., Ronconi, V., Giovannini, L., Ceccoli, L., di Tizio, V., Turchi, F., & Boscaro, M. (2011) · L Endocrinologo · doi:10.1007/bf03344805
MECHANISMS OF CARDIOVASCULAR DISEASE RISKS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
Studen, K. B., Preželj, J., Kocjan, T., & Pfeifer, M. (2009) · Slovenian Medical Journal
Neues zu Aldosteron und dem Mineralokortikoidrezeptor
Fiebeler, A. (2007) · Der Nephrologe · doi:10.1007/s11560-007-0119-6
Controversies on the Diagnosis of Primary Aldosteronism
Mulatero, P., Verhovez, A., Bertello, C., Saglio, E., Monticone, S., & Veglio, F. (2006) · High Blood Pressure & Cardiovascular Prevention · doi:10.2165/00151642-200613040-00005
Self-citationHipertensión arterial mineralocorticoidea
Carlos Fardella, B., Carvajal, C. A., Campino, C., Tapia, A., García, H., & Martínez‐Aguayo, A. (2013) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(13)70225-6
“Por su parte, los pacientes con HAP tienen mayor riesgo de eventos cardiovasculares que los esperados para sus niveles de presión arterial, mayor hipertrofia ventricular izquierda, accidente vascular encefálico, e IAM que los pacientes hipertensos esenciales (10).”
Karashima, S. (2013) · Journal of Hypertension Open Access · doi:10.4172/2167-1095.1000130
“Patients with PA have a significantly higher prevalence of metabolic syndrome than those with essential hypertension (EHT) [9-11].”
BackgroundPRIMARY ALDOSTERONISM STUDIES ON SCREENING, OUTCOME OF ADRENALECTOMY AND FUNCTIONAL PATHOLOGY
Volpe, C. (2013) · Figshare
CMS and Type 2 Diabetes Mellitus: Bound Together by the Renin Angiotensin Aldosterone System
Gupta, D., Lastra, G., Manrique, C. M., & Sowers, J. R. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-186-8_13
3) Aldosterone and Adult Disease
Nagase, M., & Fujita, T. (2008) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.97.2160
Nagase, M. (2012) · Journal of The Society of Japanese Women Scientists · doi:10.5939/sjws.12003
Prevention of Adverse Metabolic Consequences of Adipocyte Dysfunction Using MR Antagonists
Caprio, M., Marzolla, V., & Armani, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-805421-5.00007-0
Hiperaldosteronismo primario y otras formas de hipertension arterial endocrina
Carvajal, C. A., Baudrand, R. F., & Fardella, C. (2016) · ARS MEDICA Revista de Ciencias Médicas · doi:10.11565/arsmed.v41i2.386
“…su parte, los pacientes con HAP tienen mayor riesgo de eventos cardiovasculares que los esperados para sus niveles de presión arterial, mayor hipertrofia ventricular izquierda, accidente vascular encefálico, fibrilación auricular e IAM que los pacientes hipertensos esenciales (Fallo et al. 2006).”
BackgroundTanaka, A. (2004) · Harvard University Asia Center eBooks · doi:10.1163/9781684176199_004
Hypertension from the perspective of the less common situations
Krátká, Z., & Petrák, O. (2016) · Medicína pro praxi · doi:10.36290/med.2016.026
Primary Aldosteronism: From Genetic Causes to Clinical Guidelines
Nanba, K., Shibata, H., & Rainey, W. E. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_6
Secondary forms of hypertension, classification and common causes
Šomlóová, Z. (2011) · Cor et Vasa · doi:10.33678/cor.2011.111
Is target organ damage more frequent in primary aldosteronism than in essential hypertension?
Indra, T., & Holaj, R. (2011) · Cor et Vasa · doi:10.33678/cor.2011.113
Impact of Endocrine Disorders on Typical and Atypical Cardiovascular Risk Factors
Perticone, M., & Perticone, F. (2019) · Endocrinology · doi:10.1007/978-3-319-66362-3_1-1
SHIDLOVSKYI, V. O., Shidlovsky, A. V., & Кравців, В. В. (2019) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.15.4.2019.174824
SHIDLOVSKYI, V. O., Shidlovskyi, O. V., Sheremet, M. I., Sheremet, N. A., Tkachuk, N. P., Maksymyuk, V. V., Tarabanchuk, V. V., GYRLA, Y. V., & Bilookyi, O. V. (2019) · Romanian Journal of Medical Practice · doi:10.37897/rjmp.2019.4.4
“Consequently, PHA in most patients is combined F. Fallo et al. (2006) studied the possible combinations of metabolic syndrome components and their frequency in patients with PHA and EH (Table 2).”
Backgroundvan der Heijden, C. D. C. C., Smeets, E., Aarntzen, E. H. J. G., Wesseling, M., de Jager, S. C. A., & Riksen, N. P. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002727
“Diabetes mellitus is common [2], and cardiovascular risk elevated independently of blood pressure (BP) [3].”
Backgroundda Cruz, M. R. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2020.tde-11022021-131315
腹腔鏡下スリーブ状胃切除術後に、アルドステロン自律分泌が消失した一例
玉井, 宏., 森本, 晶., 木俵, 米., 八木, 千., Kakutani, M., 松尾, 俊., Miyoshi, A., 角谷学, 吉村, 知., 倉橋, 康., et al. (2021) · Folia Endocrinologica Japonica · doi:10.1507/endocrine.97.s.update_74
(2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3281de7489
Impact of Endocrine Disorders on Typical and Atypical Cardiovascular Risk Factors
Perticone, M., & Perticone, F. (2020) · Endocrinology · doi:10.1007/978-3-319-68729-2_1
Baudry, C., Waintrop, C., & Mosnier-Pudar, H. (2011) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(11)53860-0
Schteingart, D. E. (2010) · Yearbook of Medicine · doi:10.1016/s0084-3873(10)79815-1
CARDIOMETABOLIC DEVELOPMENT MECHANISMS OBESITY SYNDROME
Кравченко, Н. А., & Клименко, Н. Н. (2012) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2012.1.11 · Cited by 2
Avaliação dos testes da furosemida endovenosa e oral no diagnóstico do hiperaldosteronismo primário
Rezende, T. F. T. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-26062023-140837
Glucocorticoids: The culprit behind metabolic disorders in primary Aldosteronism? A narrative review
Kmieć, P., & Świątkowska−Stodulska, R. (2025) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2025.100401
Kernspintomographische myokardiale Natriumbildgebung
Wörmann, C. (2025) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-40416
Diagnostik und Komorbiditäten des primären Hyperaldosteronismus
Asbach, E. (2023) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.32650
Manosroi, W., Phudphong, P., Atthakomol, P., & Phimphilai, M. (2022) · Figshare · doi:10.6084/m9.figshare.20762958
BAGORDO, D. (2025) · IRIS Research product catalog (Sapienza University of Rome)
Impact du récepteur minéralocorticoïde sur le métabolisme énergétique
Kuhn, E. (2014) · theses.fr (ABES) · doi:10.70675/2f394ed5z2580z483cz8b59zdebe5eeab26b
Le canal calcique de type L, une cible directe de l’aldostérone dans les cardiomyocytes
Auguste, G. E. (2015) · theses.fr (ABES) · doi:10.70675/dfd8ca85z25ebz4755z8abbzf95c04c8d590
Biologically active small molecules against primary aldosteronism driver mutations
Mir-Bashiri, S. (2026) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.37207
Tang, C., Meng, L., Lan, H., Xian, J., Chen, C., Pang, L., & Qin, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1863900
Impatto cardiometabolico delle patologie surrenaliche: evidenze da studi clinici
Tizianel, I. (n.d.) · Padua Research Archive (University of Padova)
Metadata
- Authors
- Fallo, F., Veglio, F., Bertello, C., Sonino, N., Della Mea, P., Ermani, M., Rabbia, F., Federspil, G., & Mulatero, P.
- Affiliations
- University of Padua (IT)
- University of Turin (IT)
- Corresponding author
- Fallo, Francesco
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-02
- Volume
- 91
- Issue
- 2
- Pages
- 454-459
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2099583783
- Semantic Scholar
- 5b2795dc0ee3d66f4f0cf0367b9210dd5492663a
- Cited by
- 372
- References
- 61
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 12 · 2023: 16 · 2022: 14 · 2021: 16 · 2020: 22 · 2019: 26 · 2018: 23 · 2017: 23 · 2016: 18 · 2015: 17 · 2014: 17 · 2013: 22 · 2012: 23
- FWCI
- 15.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Università degli Studi di Padova
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- primary aldosteronism, metabolic syndrome, essential hypertension, hyperglycemia, aldosterone excess, glucose metabolism, cardiovascular risk, dyslipidemia, obesity
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Blood Glucose, Blood Pressure, Female, Humans, Hyperaldosteronism, Hypertension, Cholesterol, HDL, Male, Middle Aged, Prospective Studies, Triglycerides, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.